August 5, 2024—Vascular Therapies announced completion of enrollment in the ACCESS 2 trial of Sirogen, a sirolimus-eluting collagen implant that the company is developing for intraoperative local, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results